Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 1
2012 3
2013 4
2014 4
2016 5
2017 3
2018 1
2019 3
2020 8
2021 5
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Pignata S, Scambia G, Schettino C, Arenare L, Pisano C, Lombardi D, De Giorgi U, Andreetta C, Cinieri S, De Angelis C, Priolo D, Casanova C, Rosati M, Greco F, Zafarana E, Schiavetto I, Mammoliti S, Cecere SC, Salutari V, Scalone S, Farolfi A, Di Napoli M, Lorusso D, Gargiulo P, Califano D, Russo D, Spina A, De Cecio R, Chiodini P, Perrone F; MITO investigators. Pignata S, et al. Among authors: de cecio r. Lancet Oncol. 2023 Mar;24(3):286-296. doi: 10.1016/S1470-2045(23)00016-5. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052965 Clinical Trial.
Lurbinectedin in small cell lung cancer.
Manzo A, Sforza V, Carillio G, Palumbo G, Montanino A, Sandomenico C, Costanzo R, Esposito G, Laudato F, Mercadante E, La Manna C, Muto P, Totaro G, De Cecio R, Picone C, Piccirillo MC, Pascarella G, Normanno N, Morabito A. Manzo A, et al. Among authors: de cecio r. Front Oncol. 2022 Aug 30;12:932105. doi: 10.3389/fonc.2022.932105. eCollection 2022. Front Oncol. 2022. PMID: 36110944 Free PMC article. Review.
Surgery in Small-Cell Lung Cancer.
Martucci N, Morabito A, La Rocca A, De Luca G, De Cecio R, Botti G, Totaro G, Muto P, Picone C, Esposito G, Normanno N, La Manna C. Martucci N, et al. Among authors: de cecio r. Cancers (Basel). 2021 Jan 21;13(3):390. doi: 10.3390/cancers13030390. Cancers (Basel). 2021. PMID: 33494285 Free PMC article. Review.
RET Inhibitors in Non-Small-Cell Lung Cancer.
Cascetta P, Sforza V, Manzo A, Carillio G, Palumbo G, Esposito G, Montanino A, Costanzo R, Sandomenico C, De Cecio R, Piccirillo MC, La Manna C, Totaro G, Muto P, Picone C, Bianco R, Normanno N, Morabito A. Cascetta P, et al. Among authors: de cecio r. Cancers (Basel). 2021 Sep 1;13(17):4415. doi: 10.3390/cancers13174415. Cancers (Basel). 2021. PMID: 34503226 Free PMC article. Review.
Paralogous HOX13 Genes in Human Cancers.
Botti G, Cillo C, De Cecio R, Malzone MG, Cantile M. Botti G, et al. Among authors: de cecio r. Cancers (Basel). 2019 May 20;11(5):699. doi: 10.3390/cancers11050699. Cancers (Basel). 2019. PMID: 31137568 Free PMC article. Review.
Immunotherapy in Small Cell Lung Cancer.
Esposito G, Palumbo G, Carillio G, Manzo A, Montanino A, Sforza V, Costanzo R, Sandomenico C, La Manna C, Martucci N, La Rocca A, De Luca G, Piccirillo MC, De Cecio R, Botti G, Totaro G, Muto P, Picone C, Normanno N, Morabito A. Esposito G, et al. Among authors: de cecio r. Cancers (Basel). 2020 Sep 4;12(9):2522. doi: 10.3390/cancers12092522. Cancers (Basel). 2020. PMID: 32899891 Free PMC article. Review.
Targeting the EGFR T790M mutation in non-small-cell lung cancer.
Normanno N, Maiello MR, Chicchinelli N, Iannaccone A, Esposito C, De Cecio R, D'alessio A, De Luca A. Normanno N, et al. Among authors: de cecio r. Expert Opin Ther Targets. 2017 Feb;21(2):159-165. doi: 10.1080/14728222.2017.1272582. Epub 2016 Dec 23. Expert Opin Ther Targets. 2017. PMID: 28002980 Review.
The safety of atezolizumab plus chemotherapy for the treatment of metastatic lung cancer.
Manzo A, Carillio G, Montanino A, Sforza V, Palumbo G, Esposito G, Costanzo R, Sandomenico C, La Manna C, Martucci N, La Rocca A, De Luca G, Piccirillo MC, De Cecio R, Botti G, Totaro G, Muto P, Picone C, Normanno N, Morabito A. Manzo A, et al. Among authors: de cecio r. Expert Opin Drug Saf. 2020 Jul;19(7):775-783. doi: 10.1080/14740338.2020.1767584. Epub 2020 May 26. Expert Opin Drug Saf. 2020. PMID: 32400223 Review.
Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer.
Palumbo G, Esposito G, Carillio G, Manzo A, Montanino A, Sforza V, Costanzo R, Sandomenico C, La Manna C, Martucci N, La Rocca A, De Luca G, Piccirillo MC, De Cecio R, Perrone F, Totaro G, Muto P, Picone C, Normanno N, Morabito A. Palumbo G, et al. Among authors: de cecio r. Explor Target Antitumor Ther. 2020;1(2):117-130. doi: 10.37349/etat.2020.00008. Epub 2020 Apr 28. Explor Target Antitumor Ther. 2020. PMID: 36046069 Free PMC article. Review.
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Roca MS, Moccia T, Iannelli F, Testa C, Vitagliano C, Minopoli M, Camerlingo R, De Riso G, De Cecio R, Bruzzese F, Conte M, Altucci L, Di Gennaro E, Avallone A, Leone A, Budillon A. Roca MS, et al. Among authors: de cecio r. J Exp Clin Cancer Res. 2022 Mar 3;41(1):83. doi: 10.1186/s13046-022-02295-4. J Exp Clin Cancer Res. 2022. PMID: 35241126 Free PMC article.
43 results